Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centre Paul Papin
Angers, France
- Institut Bergonie
Bordeaux, France
- C.H.U. de Brest
Brest, France
- Centre Regional Francois Baclesse
Caen, France
- Chu de Grenoble - Hopital de la Tronche
Grenoble, France
- Centre Oscar Lambret
Lille, France
- Centre Leon Berard
Lyon, France
- Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes
Marseille, France
- Hopital Notre-Dame de Bon Secours
Metz, France
- Centre Regional de Lutte Contre Le Cancer - Centre Val D'Aurelle
Montpellier, France
- Centre Antoine Lacassagne
Nice, France
- Hopital Europeen Georges Pompidou
Paris, France
- Hopital Tenon
Paris, France
- Institut Jean Godinot
Reims, France
- Centre Eugene Marquis
Rennes, France
- Centre Hospitalier de Rodez
Rodez, France
- Centre Henri Becquerel
Rouen, France
- Crlcc Nantes - Atlantique
Saint-Herblain, France
- Institut Claudius Regaud
Toulouse, France
- Centre Hospitalier Universitaire Bretonneau de Tours
Tours, France
- Centre Alexis Vautrin
Vandœuvre-lès-Nancy, France
- Institut Gustave Roussy
Villejuif, France
- National Cancer Institute - Bratislava
Bratislava, Slovakia
- M. D. Anderson Cancer Center at University of Texas
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Nov 2003
- Primary completion
- 29 Mar 2012
- Completion
- 8 Feb 2023
- Last update posted
- 6 Feb 2025
- Registered enrollment
- 263
- Registry id
- NCT00104676
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.